Abstract:Neurodegenerative diseases are characterized by chronic progressive degeneration of the structure and function of the nervous system, which brings an enormous burden on patients, their families, and society. It is difficult to make early diagnosis, resulting from the insidious onset and progressive development of neurodegenerative diseases. The drugs on the market cannot cross the blood–brain barrier (BBB) effectively, which leads to unfavorable prognosis and less effective treatments. Therefore, there is an urgent demand to develop a novel detection method and therapeutic strategies. Recently, nanomedicine has aroused considerable attention for diagnosis and therapy of central nervous system (CNS) diseases. Nanoparticles integrate targeting, imaging, and therapy in one system and facilitate the entry of drug molecules across the blood–brain barrier, offering new hope to patients. In this review, we summarize the application of iron oxide nanoparticles (IONPs) in the diagnosis and treatment of neurodegenerative disease, including Alzheimer's disease (AD), Parkinson's disease (PD), and amyotrophic lateral sclerosis (ALS). We focus on IONPs as magnetic resonance imaging (MRI) contrast agents (CAs) and drug carriers in AD. What most neurodegenerative diseases have in common is that hall marker lesions are represented by protein aggregates (<a href="#B58">Soto and Pritzkow, 2018</a>). These diseases are of unknown etiology and unfavorable prognosis, and the treatments toward them are less effective (<a href="#B58">Soto and Pritzkow, 2018</a>). Such diseases usually develop in aged people, and early clinical manifestations are atypical, resulting in difficulty in early diagnosis. Recently, nanomedicine has aroused considerable attention for therapy and diagnosis of CNS diseases because it integrates targeting, imaging, and therapy in one system (<a href="#B30">Gupta et al., 2019</a>). In this review article, we first introduce the neurodegenerative diseases and commonly used MRI CAs. Then we review the application of IONPs in the diagnosis and treatment of neurodegenerative diseases with the purpose of assisting early theranostics (therapy and diagnosis).

Bioinorganic Materials for Imaging, Diagnosis and Therapy of Neurological Disease

Rare-earth based materials: an effective toolbox for brain imaging, therapy, monitoring and neuromodulation

Image post-processing in magnetic resonance imaging-negative focal epilepsy

Correction: Rare-earth Based Materials: an Effective Toolbox for Brain Imaging, Therapy, Monitoring and Neuromodulation

Inorganic Nanomaterial for Biomedical Imaging of Brain Diseases

Tailoring Materials for Epilepsy Imaging: from Biomarkers to Imaging Probes

Optical Molecular Imaging and Theranostics in Neurological Diseases Based on Aggregation-Induced Emission Luminogens

Advances of NIR Light Responsive Materials for Diagnosis and Treatment of Brain Diseases

Molecular Imaging in Traditional Chinese Medicine Therapy for Neurological Diseases.

Targeted nanotheranostics for the treatment of epilepsy through in vivo hijacking of locally activated macrophages

Rare-earth Nanomaterials for Potential Brain Disease Theranostics

The Mechanical, Optical, and Thermal Properties of Graphene Influencing Its Pre-Clinical Use in Treating Neurological Diseases

An electric-field-responsive paramagnetic contrast agent enhances the visualization of epileptic foci in mouse models of drug-resistant epilepsy

Engineering nanoprobes for magnetic resonance imaging of brain diseases

MRI magnetic compatible electrical neural interface: From materials to application

Natural Medicines for the Treatment of Epilepsy: Bioactive Components, Pharmacology and Mechanism

Application of Iron Oxide Nanoparticles in the Diagnosis and Treatment of Neurodegenerative Diseases With Emphasis on Alzheimer’s Disease

Diagnostics and theranostics of central nervous system diseases based on aggregation-induced emission luminogens

The Application of Nanotechnology for the Diagnosis and Treatment of Brain Diseases and Disorders

Metal–Organic Frameworks‐Based Nanoplatforms for the Theranostic Applications of Neurological Diseases

Harnessing the power of natural alkaloids: the emergent role in epilepsy therapy